RILYG Q1 2024 Earnings Negative EPS Reflects Challenging Period Bond Price Declines VRME Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Quarter HIMS Q1 2026 Earnings Significant EPS Miss as Loss Deepens Stock Declines Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline BR Q1 2026 Earnings Solid Earnings Beat Driven by Operational Strength OSBC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment